Vibroacoustic disease: biological effects of infrasound and low-frequency noise explained by mechanotransduction cellular signalling.

@article{AlvesPereira2007VibroacousticDB,
  title={Vibroacoustic disease: biological effects of infrasound and low-frequency noise explained by mechanotransduction cellular signalling.},
  author={M. Alves-Pereira and N. C. Castelo Branco},
  journal={Progress in biophysics and molecular biology},
  year={2007},
  volume={93 1-3},
  pages={
          256-79
        }
}
  • M. Alves-Pereira, N. C. Castelo Branco
  • Published 2007
  • Medicine, Biology
  • Progress in biophysics and molecular biology
  • At present, infrasound (0-20 Hz) and low-frequency noise (20-500 Hz) (ILFN, 0-500 Hz) are agents of disease that go unchecked. Vibroacoustic disease (VAD) is a whole-body pathology that develops in individuals excessively exposed to ILFN. VAD has been diagnosed within several professional groups employed within the aeronautical industry, and in other heavy industries. However, given the ubiquitous nature of ILFN and the absence of legislation concerning ILFN, VAD is increasingly being diagnosed… CONTINUE READING
    88 Citations
    Respiratory pathology in vibroacoustic disease: 25 years of research.
    • 13
    • PDF
    Myocardial fi brosis in rats exposed to low frequency noise
    • 12
    Immunohistochemical evaluation of cardiac connexin43 in rats exposed to low-frequency noise.
    • 13
    • PDF

    References

    SHOWING 1-10 OF 113 REFERENCES
    Vibroacoustic disease.
    • 56
    • PDF
    Vascular lesions and vibroacoustic disease
    • 23
    The clinical stages of vibroacoustic disease.
    • 50
    The clinical stages of vibroacoustic disease.
    • 54
    • PDF
    Voice acoustic patterns of patients diagnosed with vibroacoustic disease.
    • 8
    Involvement of central airways in vibroacoustic disease patients.
    • 13
    • PDF
    Vibroacoustic disease: some forensic aspects.
    • 34
    The human pericardium in vibroacoustic disease.
    • 35